Related Experiment Video
Updated: Nov 25, 2025

Improved Home Blood Pressure Control by CT-guided Ozone-mediated Renal Denervation for Patients with Resistant Hypertension
Published on: June 6, 2025
Association Between Blood Pressure Control and Coronavirus Disease 2019 Outcomes in 45 418 Symptomatic Patients With
James P Sheppard1, Brian D Nicholson1, Joseph Lee1
1From the Nuffield Department of Primary Care Health Sciences, University of Oxford, United Kingdom (J.P.S., B.D.N., J.L., D.M., J.S., C.K., J.O., N.R.J., W.H., L.A., O.V.H., S.L.-F., C.R.B., H.L., J.W., F.F., M.D.F., M.P.J., S.d.L., F.D.R.H.).
Insights
Hypertension control and COVID-19 outcomes were studied. Uncontrolled blood pressure (BP) stage 1 was linked to lower COVID-19 death odds, suggesting BP control may worsen outcomes.
Area of Science:
- Cardiology
- Infectious Diseases
- Public Health
Background:
- Hypertension is a known risk factor for severe coronavirus disease 2019 (COVID-19).
- Understanding the impact of pre-infection blood pressure (BP) control on COVID-19 outcomes is crucial for patient management.
- Previous research indicates a complex relationship between cardiovascular health and viral infection severity.
Purpose of the Study:
- To investigate the association between pre-infection blood pressure control levels and COVID-19 outcomes in hypertensive patients.
- To determine if varying degrees of blood pressure control influence COVID-19 diagnosis, hospitalization, or mortality.
- To identify potential implications for public health strategies during the COVID-19 pandemic.
Main Methods:
- Retrospective analysis of data from 460 general practices in England.
- Inclusion of adult patients with hypertension tested or diagnosed with COVID-19.
- Classification of blood pressure control into four categories: controlled, raised, stage 1 uncontrolled, and stage 2 uncontrolled.
- Multivariable logistic regression to analyze the association between BP control and primary (28-day COVID-19 death) and secondary (COVID-19 diagnosis, hospitalization) outcomes.
Main Results:
- Of 45,418 patients, 26.3% had controlled blood pressure.
- Patients with stage 1 uncontrolled blood pressure (140/90-159/99 mm Hg) showed significantly lower odds of 28-day COVID-19 death (OR, 0.76; 95% CI, 0.62-0.92) compared to those with controlled BP.
- No significant association was found between blood pressure control levels and COVID-19 diagnosis or hospitalization rates.
Conclusions:
- Pre-infection blood pressure control may be associated with differential COVID-19 mortality risk.
- Patients with less controlled blood pressure (stage 1 uncontrolled) exhibited lower odds of COVID-19 death.
- These findings may relate to underlying atherosclerosis and target organ damage in patients with less controlled BP, suggesting a need for tailored public health guidance, such as enhanced social distancing for vulnerable hypertensive individuals.
Abstract:
Hypertension has been identified as a risk factor for coronavirus disease 2019 (COVID-19) and associated adverse outcomes. This study examined the association between preinfection blood pressure (BP) control and COVID-19 outcomes using data from 460 general practices in England. Eligible patients were adults with hypertension who were tested or diagnosed with COVID-19. BP control was defined by the most recent BP reading within 24 months of the index date (January 1, 2020). BP was defined as controlled (<130/80 mm Hg), raised (130/80-139/89 mm Hg), stage 1 uncontrolled (140/90-159/99 mm Hg), or stage 2 uncontrolled (≥160/100 mm Hg). The primary outcome was death within 28 days of COVID-19 diagnosis. Secondary outcomes were COVID-19 diagnosis and COVID-19-related hospital admission. Multivariable logistic regression was used to examine the association between BP control and outcomes. Of the 45 418 patients (mean age, 67 years; 44.7% male) included, 11 950 (26.3%) had controlled BP. These patients were older, had more comorbidities, and had been diagnosed with hypertension for longer. A total of 4277 patients (9.4%) were diagnosed with COVID-19 and 877 died within 28 days. Individuals with stage 1 uncontrolled BP had lower odds of COVID-19 death (odds ratio, 0.76 [95% CI, 0.62-0.92]) compared with patients with well-controlled BP. There was no association between BP control and COVID-19 diagnosis or hospitalization. These findings suggest BP control may be associated with worse COVID-19 outcomes, possibly due to these patients having more advanced atherosclerosis and target organ damage. Such patients may need to consider adhering to stricter social distancing, to limit the impact of COVID-19 as future waves of the pandemic occur.
Related Concept Videos
Hypertension and Regulation of Blood Pressure
Blood Pressure
The average BP in an adult is typically around 120/80 mmHg (millimeters of mercury). In this measurement, the numerator (120) indicates the systolic pressure, which is the pressure in the arteries during the contraction of the heart's ventricles as blood is expelled. The denominator (80) represents the...
Blood Pressure
Hypertension III: Clinical Manifestations and Diagnostic Studies
Factors affecting Blood pressure
Physiological Factors:
Hypertension II: Pathophysiology

